Published in Cancer Res on March 01, 2001
Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ (2008) 3.08
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol (2005) 2.72
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst (2009) 2.22
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res (2010) 2.14
Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine (2008) 2.13
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med (2006) 2.10
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev (2008) 2.10
Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis (2010) 1.83
Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer (2008) 1.48
EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer (2014) 1.44
Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res (2008) 1.40
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis (2009) 1.35
Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer (2007) 1.32
Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera. J Virol (2006) 1.20
Genital HPV infection and related lesions in men. Prev Med (2011) 1.19
Invited commentary: Biological and clinical insights from epidemiologic research into HIV, HPV, and anal cancer. Am J Epidemiol (2013) 1.16
Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. J Infect Dis (2011) 1.05
More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis (2006) 1.03
The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol (2008) 1.02
No evidence for human papillomavirus in the etiology of colorectal polyps. Cancer Epidemiol Biomarkers Prev (2011) 1.01
Is the incidence of invasive vulvar cancer increasing in the United States? Cancer Causes Control (2009) 1.01
Anal cancer - a review. Int J Health Sci (Qassim) (2012) 1.01
Cervical carcinoma rates among young females in the United States. Obstet Gynecol (2012) 1.00
Immunologic treatments for precancerous lesions and uterine cervical cancer. J Exp Clin Cancer Res (2014) 0.96
Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection. PLoS One (2013) 0.95
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer (2003) 0.95
Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2. Cancer Epidemiol Biomarkers Prev (2008) 0.94
NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes. J Virol (2009) 0.93
Alternative dosage schedules with HPV virus-like particle vaccines. Expert Rev Vaccines (2014) 0.93
Disrupted human-pathogen co-evolution: a model for disease. Front Genet (2014) 0.92
Age of diagnosis of squamous cell cervical carcinoma and early sexual experience. Cancer Epidemiol Biomarkers Prev (2009) 0.90
Immune therapy for human papillomaviruses-related cancers. World J Clin Oncol (2014) 0.86
Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer. Curr Opin Virol (2011) 0.80
HPV frequency in penile carcinoma of Mexican patients: important contribution of HPV16 European variant. Int J Clin Exp Pathol (2013) 0.80
Human papillomavirus genotyping and e6/e7 mRNA expression in greek women with intraepithelial neoplasia and squamous cell carcinoma of the vagina and vulva. J Oncol (2011) 0.79
Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women. Int J Cancer (2016) 0.78
Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngol Clin North Am (2012) 0.78
Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies. Clin Vaccine Immunol (2012) 0.78
A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers. Gynecol Oncol (2015) 0.77
Oral human papillomavirus infection in men might contribute to HPV serology. Eur J Clin Microbiol Infect Dis (2014) 0.76
Anal cancer and human papillomaviruses in heterosexual men. Curr Oncol (2008) 0.76
NFX1-123 and human papillomavirus 16E6 increase Notch expression in keratinocytes. J Virol (2013) 0.76
Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3). J Low Genit Tract Dis (2016) 0.76
Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples. J Clin Microbiol (2014) 0.75
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2000) 14.59
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41
Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (1998) 7.81
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Ovarian tumors in a cohort of infertile women. N Engl J Med (1994) 4.91
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med (1996) 4.51
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol (1996) 4.25
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med (1997) 4.21
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol (1991) 4.18
Selection and characterization of bovine aortic endothelial cells. In Vitro (1978) 4.09
BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med (1996) 3.83
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry (1994) 3.75
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 3.65
Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature (1996) 3.61
Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol (1988) 3.54
Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst (1997) 3.51
Widespread presence of histologically occult cytomegalovirus. Hum Pathol (1984) 3.45
Biochemical transformation of mouse cells by fragments of herpes simplex virus DNA. Cell (1977) 3.38
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis (2000) 3.36
Epidemiology of genital human papillomavirus infection. Epidemiol Rev (1988) 3.32
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
Replication of smooth muscle cells in vascular disease. Circ Res (1986) 2.98
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A (1990) 2.90
Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst (1998) 2.86
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83
Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol (2000) 2.77
Correlation between tumor induction and the large external transformation sensitive protein on the cell surface. Proc Natl Acad Sci U S A (1976) 2.76
Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst (2001) 2.73
Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest (1991) 2.70
Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science (1986) 2.67
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev (1997) 2.65
Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol (1998) 2.64
Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest (1992) 2.62
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol (1992) 2.61
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest (1993) 2.60
Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis. J Infect Dis (1983) 2.60
International system for human gene nomenclature (1979) ISGN (1979). Cytogenet Cell Genet (1979) 2.58
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med (1998) 2.58
Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.58
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology (1994) 2.51
Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest (1981) 2.46
Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA (1995) 2.43
Expression of the sis gene by endothelial cells in culture and in vivo. Proc Natl Acad Sci U S A (1984) 2.41
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res (1991) 2.39
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc Natl Acad Sci U S A (1991) 2.38
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer Inst (1995) 2.36
Clinical characteristics of different histologic types of breast cancer. Br J Cancer (2005) 2.36
Developmentally regulated production of platelet-derived growth factor-like molecules. Nature (1984) 2.30
Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res (1985) 2.28
Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol (1994) 2.26
The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature (1983) 2.26
Characteristics of women with and without breast augmentation. JAMA (1997) 2.26
PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol (1990) 2.26
Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A (1983) 2.26
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest (1995) 2.23
Detection of herpes simplex RNA in human sensory ganglia. Virology (1979) 2.23
The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis (1996) 2.21
Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest (1996) 2.20
Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol (2001) 2.18
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood (1997) 2.15
Limited transcription of the herpes simplex virus genome when latent in human sensory ganglia. J Virol (1982) 2.12
Risk factors for sudden infant death syndrome: changes associated with sleep position recommendations. J Pediatr (2001) 2.09
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 2.06
Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci U S A (1994) 2.02
Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest (1995) 2.02
Cell replication in the aortic endothelium: a new method for study of the problem. Lab Invest (1973) 1.99
The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol (1994) 1.97
Transfer of immunoglobulins IgG, IgA and IgM to lacteal secretions in the parturient sow and their absorption by the neonatal piglet. Biochim Biophys Acta (1969) 1.96
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer (2005) 1.96
Cervical cancer screening among Cambodian-American women. Cancer Epidemiol Biomarkers Prev (1999) 1.95
Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst (2001) 1.95